Hereditary Leiomyomatosis And Renal Cell Cancer
What's New
Last Posted: Aug 17, 2023
- Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of hereditary Leiomyomatosis and renal cell cancer (HLRCC).
Daniel R Crooks, et al. Human molecular genetics 2023 0 - Fumarate Hydratase Variants and their Association with Paraganglioma/Pheochromocytoma.
Zavoshi Shirin, et al. Urology 2023 0 - A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC).
Bhola Priya T, et al. Familial cancer 2018 0 (4) 615-620 - Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients.
Liu Chengbao, et al. Histopathology 2019 0 (3) 354-365 - Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization.
Sánchez-Heras A Beatriz, et al. Cancers 2020 0 (11) - Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas.
Furuya Mitsuko, et al. Journal of clinical pathology 2020 0 (12) 819-825 - Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives.
Catarina Tavares, et al. Journal of kidney cancer and VHL 2022 0 (2) 27-31 - Fumarate hydratase gene germline variants and mosaicism associated with pheochromocytoma and paraganglioma.
Ma Xiaosen, et al. Annals of the New York Academy of Sciences 2022 0 (1) 262-270 - Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes.
Al-Shinnag Mohammad et al. Frontiers in oncology 2021 11738822 - Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy John M et al. Medical oncology (Northwood, London, England) 2019 Jul 36(9) 74 - MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas.
Heikkinen Tuomas, et al. Human reproduction open 2018 0 (4) hoy020 - CLINGEN Actionability Report for Familial papillary renal cell carcinoma 1 - MET
ClinGen Actionability Working Group - CLINGEN Actionability Report for Hereditary Leiomyomatosis and Renal Cell Cancer - FH
ClinGen Actionability Working Group - PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Schultz Kris Ann P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jun 23(12) e76-e82 - Fine mapping of the uterine leiomyoma locus on 1q43 close to a lncRNA in the RGS7-FH interval.
Aissani Brahim, et al. Endocrine-related cancer 2015 8 (4) 633-43 - Kidney (Renal Cell) Cancer—Patient Version
- Multiple hits for the association of uterine fibroids on human chromosome 1q43.
Aissani Brahim, et al. PloS one 2013 0 (3) e58399 - MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen Netta, et al. European journal of human genetics : EJHG 2013 11 (11) 1300-3 - Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.
Lehtonen Rainer, et al. The American journal of pathology 2004 1 (1) 17-22 - Hereditary leiomyomatosis and renal cell cancer
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: